Calzia R, Ciravegna B, Navone C, Tolentino P
Boll Ist Sieroter Milan. 1982;61(4):347-56.
In 21 subjects HBsAg positive affected by different forms of chronic hepatitis and in one carrier we compared the presence in the liver of HBsAg, HBcAg and delta studied by means of I.F. and the presence of serological markers of hepatitis B virus infection. By the I.F. test, HBsAg was present in all cases, HBcAg in 15 cases (71%), delta in 8 cases (38%). These percentages are almost the same as those of other researches in chronic hepatitis in immunodepressive treatment. About the serological markers, HBsAg and HBcAb were present in 100% of cases, while, regarding the e-anti e system, HBeAg was present in 12 cases (57%) and HBeAb in 7 (33%). In the work effected there is no relation between delta and HBeAg because in 50% of the positive delta subjects there was HBeAb. On the contrary HBcAg and HBeAg are strictly correlated. Therefore the antigens core and delta are not interdependent. We wanted to verify the existence of relation between HBcAg and HBeAg and came to the conclusion that this relation exists in 17 out of 21 subjects (81%). In our researches is clear the long persistence of the hepatic antigens without any connection with the time of treatment and the course of the various chronic hepatitis. The change in the serum from HBeAg to HBeAb occurred in many improved cases but not in all of them. We presume that the long immunodepressive treatment (about 4 years) has influenced our results.
在21例患有不同形式慢性肝炎的HBsAg阳性患者以及1例携带者中,我们通过免疫荧光法比较了肝脏中HBsAg、HBcAg和δ抗原的存在情况,以及乙肝病毒感染血清学标志物的存在情况。通过免疫荧光试验,所有病例均存在HBsAg,15例(71%)存在HBcAg,8例(38%)存在δ抗原。这些百分比与其他慢性肝炎免疫抑制治疗研究的结果几乎相同。关于血清学标志物,100%的病例存在HBsAg和HBcAb,而关于e抗原-e抗体系统,12例(57%)存在HBeAg,7例(33%)存在HBeAb。在本研究中,δ抗原与HBeAg之间没有关联,因为50%的δ抗原阳性患者存在HBeAb。相反,HBcAg与HBeAg密切相关。因此,核心抗原和δ抗原并非相互依存。我们想验证HBcAg与HBeAg之间是否存在关联,得出的结论是,21例患者中有17例(81%)存在这种关联。在我们的研究中,肝脏抗原长期持续存在,与治疗时间和各种慢性肝炎的病程无关,这一点很明显。血清中从HBeAg转变为HBeAb在许多病情改善的病例中出现,但并非所有病例都是如此。我们推测长期的免疫抑制治疗(约4年)影响了我们的结果。